(redirected from Genodermatoses)
Also found in: Medical, Encyclopedia.


n. genodermatosis, una condición de la piel de origen genético.
References in periodicals archive ?
[1] Division of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria; [2] Institute of Pharmacy/Pharmacognosy, University of Innsbruck, Innsbruck, Austria; [3] EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; [4] Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria; [5] Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria
Lipoid proteinosis (LP) is a very rare autosomal recessive genodermatoses whose true incidence is not known.
Harlequin ichthyosis was one of the first genodermatoses to be recorded.
Genodermatoses were seen in 3% of the cases and included autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome, aplasia cutis congenita, hypomelanosis of Ito, osteogenesis imperfecta, and incontinentia pigmenti, among others.
The pathological skin manifestations may be classified into infective skin disorders, non-infective skin dermatoses, genodermatoses and developmental skin defects.
Kindler syndrome: a focal adhesion genodermatoses. Br J Dermatol 2009; 160: 233-42.
Choudhary, "Reticulate acropigmentation of dohi: A case report with insight into genodermatoses with mottled pigmentation," Indian Journal of Dermatology, vol.
The risk factors that lead to SCC development can be divided into extrinsic (UVA, ionizing radiation, human papilloma virus (HPV), and chemical substances) and intrinsic (genodermatoses, immunosuppression, preexisting skin lesion, and preexisting actinic keratosis).
E, Genetics and Genodermatoses in Burns, T., Stephen Breathnach, S., Cox, N., Griffiths, C., Editors.
The most prevalent disorders by category were dermatitis (67.8%), infections (16.7%), pigmentary (5.5%), papulosquamous (4.5%), appendageal (3.1%), vascular (2.4%) and genodermatoses (1.2%) (Table 1 and Fig.
Atlas of Genodermatoses, 2nd Edition (online access included)
Later, it was believed that PVA represented a stage or an outcome of various dermatoses, such as mycosis fungoides, parapsoriasis, dermatomyositis, scleroderma, lupus erythematosus, lichen ruber planus, genodermatoses, and so on.